Purpose: Currently, radiologic response of brain tumors is assessed according to the
Macdonald criteria 10 weeks from the start of therapy. There exists a critical need to identify …

Studies investigating dynamic susceptibility contrast magnetic resonance imaging-
determined relative cerebral blood volume (rCBV) maps as a metric of treatment response …

Purpose Assessment of radiologic response (RR) for brain tumors utilizes the Macdonald
criteria 8 to 10 weeks from the start of treatment. Diffusion magnetic resonance imaging …

Background The inability of structural MRI to accurately measure tumor response to therapy
complicates care management for patients with gliomas. The purpose of this study was to …

Background The aim of this study was to investigate changes in structural magnetic
resonance imaging (MRI) according to the RANO criteria and perfusion-and permeability …

Abstract Purpose Glioblastoma Multiforme (GBM) is the most common and lethal primary
brain tumor in adults. The goal of this study was to test the predictive value of MR …

BACKGROUND AND PURPOSE: Dynamic contrast-enhanced T1-weighted perfusion MR
imaging is much less susceptible to artifacts, and its high spatial resolution allows accurate …

Aside from bidimensional measurements from conventional contrast-enhanced MRI, there
are no validated or FDA-qualified imaging biomarkers for high-grade gliomas. However …

Introduction Magnetic resonance (MR) diffusion-weighted imaging (DWI), dynamic
susceptibility contrast-enhanced perfusion imaging (DSC), and MR spectroscopy (MRS) …

Background Early and accurate prediction of response to cancer treatment through imaging
criteria is particularly important in rapidly progressive malignancies such as Glioblastoma …